Figures
Abstract
Xanthine dehydrogenase (XDH) is a molybdenum cofactor (Moco) requiring enzyme that catabolizes hypoxanthine into xanthine and xanthine into uric acid, the final steps in purine catabolism. Human patients with mutations in XDH develop xanthinuria which can lead to xanthine stones in the kidney, recurrent urinary tract infections, and renal failure. Currently, there are no therapies for treating human XDH deficiency. Thus, understanding mechanisms that maintain purine homeostasis is an important goal of human health. Here, we used the nematode Caenorhabditis elegans to model human XDH deficiency using two clinically relevant paradigms: Moco deficiency or loss-of-function mutations in xdh-1, the C. elegans ortholog of XDH. Both Moco deficiency and xdh-1 loss of function caused the formation of autofluorescent xanthine stones in C. elegans. Surprisingly, only 2% of xdh-1 null mutant C. elegans developed a xanthine stone, suggesting additional pathways may regulate this process. To uncover such pathways, we performed a forward genetic screen for mutations that enhance the penetrance of xanthine stone formation in xdh-1 null mutant C. elegans. We isolated multiple loss-of-function mutations in the gene sulp-4 which encodes a sulfate permease homologous to human SLC26 anion exchange proteins. We demonstrated that SULP-4 acts cell-nonautonomously in the excretory cell to limit xanthine stone accumulation. Interestingly, sulp-4 mutant phenotypes were suppressed by mutations in genes that encode for cystathionase (cth-2) or cysteine dioxygenase (cdo-1), members of the sulfur amino acid catabolism pathway required for production of sulfate, a substrate of SULP-4. We propose that sulfate accumulation caused by sulp-4 loss of function promotes xanthine stone accumulation. We speculate that sulfate accumulation causes osmotic imbalance, creating conditions in the intestinal lumen that favor xanthine stone accumulation. Supporting this model, a mutation in osm-8 that constitutively activates the osmotic stress response also promoted xanthine stone accumulation in an xdh-1 mutant background. Thus, our work establishes a C. elegans model for human XDH deficiency and identifies the sulfate permease sulp-4 as a critical player controlling xanthine stone accumulation.
Citation: Snoozy J, Bhattacharya S, Johnson B, Fettig RR, Van Asma A, Brede C, et al. (2025) XDH-1 inactivation causes xanthine stone formation in Caenorhabditis elegans which is inhibited by SULP-4-mediated anion exchange in the excretory cell. PLoS Biol 23(9): e3003410. https://doi.org/10.1371/journal.pbio.3003410
Academic Editor: Mark J. Alkema, UMass Chan Medical School, UNITED STATES OF AMERICA
Received: January 24, 2025; Accepted: September 11, 2025; Published: September 24, 2025
Copyright: © 2025 Snoozy et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Whole genome sequencing data for C. elegans strains have been deposited at the NIH Sequence Read Archive (SRA) under accession PRJNA1208078. All other relevant data are within the paper and its Supporting information files.
Funding: Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number R35GM146871 (to K.W.). A.V.A. was supported by the National Science Foundation Division of Biological Infrastructure under award number 1756912. C.B. was supported by the National Institute of Childhood Health and Human Development of the National Institutes of Health under award number R25HD097633. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: DIC, differential interference contrast; EMS, ethyl methanesulfonate; ICP-MS, inductively coupled plasma mass spectrometry; Moco, molybdenum cofactor; NGM, nematode growth media; pnp-1, purine nucleoside phosphorylase; qPCR, quantitative PCR; SRA, sequence read archive; SUOX-1, sulfite oxidase; WT, wild-type; XDH, xanthine dehydrogenase
Introduction
Purines are an abundant and fundamental metabolite class that are essential for the generation of RNA and DNA molecules and purine nucleotides are critical energy sources (ATP) and signaling molecules (GTP). Failures in purine metabolism can lead to both common and rare diseases. For instance, oncogenic mutations activate nucleotide biosynthetic capacity in diverse cancers, promoting cancer progression [1]. Mutations in enzymes in the purine metabolic pathway cause rare inborn errors of metabolism such as Lesch–Nyhan syndrome, purine nucleoside phosphorylase deficiency, and xanthinuria [2–5]. Thus, understanding the mechanisms that impact purine homeostasis is an important goal of human health.
Xanthinuria, an inborn error of purine metabolism, is caused by inactivation of xanthine dehydrogenase (XDH), the terminal enzyme in purine catabolism that oxidizes hypoxanthine to xanthine and xanthine to uric acid [6] (Fig 1A). There are two types of human xanthinuria; type I is caused by mutations in the gene encoding the xanthine dehydrogenase enzyme and type II is caused by mutations in genes essential for the synthesis of the molybdenum cofactor, an essential prosthetic group for XDH [4,5]. Both forms of xanthinuria present with high levels of xanthine in the urine and low levels of uric acid which can result in the formation of xanthine stones in kidneys and muscles, sometimes causing renal failure. There is currently no curative therapy for xanthinuria, however, high fluid intake and low purine diets are recommended for patients [7].
(A) The role of Moco in Caenorhabditis elegans metabolism. We highlight i) pathways for Moco synthesis and import, ii) sulfur amino acid catabolism governed by cystathionase (CTH-2/CTH), cysteine dioxygenase (CDO-1/CDO), and Moco-requiring sulfite oxidase (SUOX-1/SUOX), and iii) purine catabolism controlled by purine nucleoside phosphorylase (PNP-1/PNP) and the Moco-requiring xanthine dehydrogenase (XDH-1/XDH). C. elegans enzymes (blue) and their human homologs (red) are displayed. (B) Wild-type (WT) and mutant C. elegans were cultured on WT (black, Moco+) or ΔmoaA mutant (red, Moco−) Escherichia coli and assessed for the formation of xanthine stones over the first 3 days of adulthood. Individual data points represent biological replicates. Mean and standard deviation are displayed. Complete information regarding sample size and individuals scored per biological replicate is found in S2 Table. (C) Brightfield (left) and fluorescent (right) images of the posterior of xdh-1(ok3234) mutant adult C. elegans cultured on WT E. coli. Xanthine stones are highlighted (yellow arrowheads). The blue box indicates the region magnified in the lower panels. Scale bar is 250 μm (top) or 50 μm (bottom).
Molybdenum cofactor (Moco) is an essential prosthetic group required for development in animals ranging from the nematode Caenorhabditis elegans to humans [4,8]. Moco is synthesized by an ancient and conserved biosynthetic pathway [9]. C. elegans has recently emerged as a powerful model system for studying Moco biology, and the genes that encode the Moco biosynthetic enzymes are termed moc in C. elegans for MOlybdenum Cofactor biosynthesis [8,10]. In addition to endogenous Moco synthesis, C. elegans can also acquire and use Moco from its bacterial diet [8,11,12]. Given its genetic tractability and the ability to manipulate animal Moco content by simple dietary manipulation, C. elegans is a useful model for understanding the biology of Moco and Moco-requiring enzymes, such as XDH-1 (Fig 1A).
Here, we genetically explored the formation of xanthine stones in C. elegans, which emerged during Moco deficiency or in xdh-1 mutant C. elegans, mirroring type I and type II human xanthinuria [4,5]. Surprisingly, only a small percentage of Moco-deficient and xdh-1 mutant C. elegans developed xanthine stones, suggesting additional parallel pathways for limiting stone formation. To identify novel regulators of xanthine stone accumulation, we performed an unbiased chemical mutagenesis screen for mutations that enhanced the penetrance of xanthine stone formation in xdh-1 mutant animals. In this screen, we recovered five loss-of-function alleles of sulp-4, a gene which encodes a member of the sulfate permease family of transporters with homology to human SLC26 transporters [13]. We demonstrated that SULP-4 acts in the C. elegans excretory cell, analogous to the human kidney, to inhibit the accumulation of xanthine stones [14]. We further showed that sulp-4 was required for normal development. Interestingly, we found that phenotypes caused by sulp-4 loss of function were suppressed by inactivating mutations in cth-2 or cdo-1, genes that encode core members of the sulfur amino acid catabolism pathway (Fig 1A) [8]. We suggest that sulp-4 loss of function causes sulfate accumulation. Disruption of cth-2 or cdo-1 impairs endogenous sulfate production, thereby suppressing the phenotypes observed in sulp-4 mutant animals. Sulfate accumulation may cause an osmotic imbalance that leads to an increased rate of xanthine stone formation in the intestinal lumen. This model is supported by our observation that a mutation in osm-8, a key regulator of osmotic homeostasis, also promoted xanthine stone accumulation in an xdh-1 mutant background [15]. Thus, our work establishes a C. elegans model for the rare genetic disease xanthinuria and identifies sulp-4 as a potent genetic modifier of this disease pathology in C. elegans, likely acting through disrupted osmotic homeostasis.
Results
XDH-1 inactivation caused the accumulation of xanthine stones in C. elegans
To explore the pathology of Moco deficiency in the nematode C. elegans, we cultured cth-2; moc-1 and moc-1 cdo-1 double mutant animals on wild type (Moco replete) or ΔmoaA mutant (Moco deficient) Escherichia coli. The moc-1 mutation prevents the endogenous synthesis of Moco while the cth-2 and cdo-1 mutations suppress the lethality typically associated with animal Moco deficiency [8]. cth-2 encodes cystathionase which converts cystathionine to cysteine and cdo-1 encodes cysteine dioxygenase which oxidizes cysteine to cysteinesulfinate ultimately producing sulfites (Fig 1A). Sulfites are extremely reactive and are detoxified to sulfate by the Moco-requiring sulfite oxidase (SUOX-1) enzyme. Thus, by changing the dietary E. coli, we can control whether the animals have Moco. When culturing cth-2; moc-1 double mutant animals on Moco− E. coli, we surprisingly observed animals that developed autofluorescent stones, typically found in the posterior of the intestine. Fifty-four percent of cth-2; moc-1 animals fed a Moco− diet developed an autofluorescent stone while 0% of cth-2; moc-1 animals developed an autofluorescent stone when fed a diet that provided Moco. We observed similar results for moc-1 cdo-1 double mutant animals where 17% of animals developed an autofluorescent stone on Moco− E. coli and 0% developed a stone when fed wild-type (WT) E. coli (Fig 1B). Thus, we conclude that the formation of these autofluorescent stones is caused by Moco deficiency.
Surprisingly, we also observed the formation of autofluorescent stones in 8% of WT C. elegans when cultured on Moco− E. coli. 0% of WT animals developed an autofluorescent stone when fed Moco+ E. coli (Fig 1B). This result demonstrates that dietary Moco deficiency alone is sufficient to promote the formation of autofluorescent stones. This result is surprising as WT animals are still competent to produce Moco through their endogenous biosynthetic pathway. However, these data are consistent with our recent findings that the C. elegans diet plays a significant role in promoting Moco homeostasis [12].
Given that the development of these autofluorescent stones was dependent upon dietary Moco deficiency, we reasoned that the phenotype was likely being caused by inactivation of one of the four animal Moco-requiring enzymes (sulfite oxidase, xanthine dehydrogenase, aldehyde oxidase, and mitochondrial amidoxime reducing component) [9]. Interestingly, inactivation of the Moco-requiring enzyme xanthine dehydrogenase causes the accumulation of insoluble and fluorescent xanthine stones in organisms as diverse as plants, fruit flies, and humans [5,16–20]. We therefore hypothesized that the autofluorescent stones we observed during C. elegans Moco deficiency were xanthine stones. To test this, we looked for the presence of autofluorescent stones in animals carrying the ok3234 null mutation in xdh-1, the C. elegans orthologue of xanthine dehydrogenase. In C. elegans, XDH-1 is expressed in the intestine, excretory cell, and neurons [21]. When we cultured xdh-1 null mutant C. elegans on WT E. coli we indeed observed the formation of highly autofluorescent stones in 2% of animals (Fig 1B and 1C). Thus, xdh-1 was necessary for inhibiting the formation of autofluorescent stones. Consistent with their presence in diverse models of XDH-1-deficiency, we propose that the autofluorescent stones we observe during Moco− and XDH-1-deficiency in C. elegans are xanthine stones.
sulp-4 inhibited the formation of xanthine stones
XDH-1 functions at the end of the purine catabolism pathway to oxidize hypoxanthine to xanthine and xanthine to uric acid (Fig 1A). Given the critical position of XDH-1 in purine metabolism, we were surprised that only 2% of xdh-1 null mutant animals developed a xanthine stone. This result suggests the existence of parallel pathways for maintaining purine homeostasis. To identify additional regulators of purine metabolism, we performed an unbiased chemical mutagenesis screen for mutations that enhanced the penetrance of the xanthine stone phenotype. We mutagenized xdh-1 mutant C. elegans with ethyl methanesulfonate (EMS) and cultured the newly mutagenized animals for two generations allowing newly induced mutations to become homozygous [22]. We then cloned single mutagenized F2 animals onto their own petri dish and screened for clones where we observed a high fraction of F3 progeny developing xanthine stones.
Here, we describe five new EMS-induced recessive loss-of-function mutations that caused a high penetrance of xanthine stone formation in an xdh-1 mutant background, rae299, rae302, rae319, rae320, and rae326 (see Materials and methods). These mutant alleles were prioritized because they displayed strong enhancement of xanthine stone formation and formed a complementation group, indicating they affect a single gene (see Materials and methods). To identify the causative genetic lesion in these new mutant strains, genomic DNA from all five strains was analyzed via whole-genome sequencing. Our complementation studies suggested that the mutant strains should have novel mutations in a common gene. Only one gene, sulp-4, was uniquely mutated in all five strains, strongly suggesting these mutations were causative for the enhanced penetrance of xanthine stone formation in the xdh-1 mutant animals (Fig 2A and 2B and S1 Table). Among the newly isolated sulp-4 alleles, we found 3 missense and 2 splice site mutations. Based on their recessive nature and molecular identities, we propose that these are loss-of-function alleles of sulp-4.
(A) sulp-4 locus. Gray boxes are exons and lines are introns. The regions that encode the SLC26/SulP sulfate permease domain (orange) and STAS domain (blue) are displayed. The red lines display the location of new EMS-induced lesions that enhanced the formation of xanthine stones in an xdh-1(ok3234) mutant background. rae334 (purple) is a deletion allele generated using CRISPR/Cas9 technology. (B) Xanthine stone formation was assessed for sulp-4(rae319) single mutant and xdh-1(ok3234) mutant Caenorhabditis elegans with wild-type (WT) or mutant sulp-4(rae319, rae302, rae326, rae299, rae320, or rae334). ****p < 0.0001, ns, p > 0.05, ordinary one-way ANOVA. Individual data points represent biological replicates. Mean and standard deviation are displayed. Complete information regarding sample size and individuals scored per biological replicate is found in S2 Table. (C) Differential interference contrast image of xdh-1(ok3234); sulp-4(rae319) C. elegans at the L4 stage of development. Blue box indicates the region magnified in the lower panel. The yellow arrowhead identifies the xanthine stone. The yellow asterisk identifies the lumen of the intestine. The yellow plus sign identifies the rectum. Scale bars are 100 μm (top) and 10 μm (bottom). (D and E) WT, sulp-4(rae319), and sulp-4(rae334) mutant C. elegans were synchronized at the first stage of larval development and cultured for 72 hours on WT Escherichia coli. Animal length and developmental stage were determined. (D) Individual datapoints are displayed as are the mean and standard deviation. The sample size is 15 individuals per genotype. ****p < 0.0001, ordinary one-way ANOVA. (E) Sample size is the individuals assayed and is displayed above the bar graph for each genotype. (F) The hatching rate of newly laid WT, sulp-4(rae319), and sulp-4(rae334) mutant C. elegans embryos was determined. Individual data points represent biological replicates. Mean and standard deviation are displayed. Complete information regarding sample size and individuals scored per biological replicate is found in S2 Table. **p < 0.01 or ns, p > 0.05, ordinary one-way ANOVA.
To test the hypothesis that loss of sulp-4 function causes enhanced xanthine stone accumulation in an xdh-1 mutant, we used CRISPR/Cas9 to engineer a new sulp-4 deletion allele, rae334 [23,24]. The sulp-4(rae334) allele is a 683 bp deletion that eliminates part of exon 1, all of exons 2 and 3, and part of exon 4 (Fig 2A). Thus, we propose that sulp-4(rae334) encodes a null allele. The sulp-4(rae334) allele strongly enhanced the penetrance of xanthine stone formation in xdh-1 mutant C. elegans, phenocopying the sulp-4 alleles isolated in our EMS screen (Fig 2B). These data demonstrate that the sulp-4 lesions identified by whole genome sequencing cause xanthine stone accumulation in xdh-1 mutant animals. Furthermore, these data show that sulp-4 acts in parallel with xdh-1 to inhibit the accumulation of xanthine stones.
The xanthine stones observed in xdh-1; sulp-4 double mutant animals localized to the posterior of the C. elegans intestinal lumen, consistent with the localization of the stones observed in xdh-1 mutant animals (Fig 2C). In addition to observing xanthine stones at a higher frequency in xdh-1; sulp-4 mutant animals, the xanthine stones were also much larger suggesting that sulp-4 loss of function enhances both the penetrance and expressivity of the xanthine stone phenotype in xdh-1 mutant animals (S1 Fig). This may reflect an increased quantity of xanthine in stones displayed by xdh-1; sulp-4 mutant animals when compared to xdh-1 single mutant animals.
We originally observed the formation of xanthine stones during conditions of Moco deficiency; cth-2; moc-1 double mutant animals feeding on Moco− E. coli. We hypothesized that the sulp-4 mutation would also enhance the formation of xanthine stones caused by Moco deficiency. To test this, we assayed xanthine stone formation in sulp-4 single mutant animals cultured on WT or Moco− E. coli. Eighty-nine percent of sulp-4 mutant animals developed xanthine stones during dietary Moco deficiency compared to 1% of sulp-4 mutant animals fed a Moco replete diet (S2A Fig). These data are consistent with our conclusion that sulp-4 functions to limit the accumulation of xanthine stones caused by XDH-1 inactivation resulting from either Moco insufficiency or an xdh-1 mutation.
sulp-4 promoted healthy larval and embryonic development
While culturing the sulp-4(rae334) mutant strain, we observed that mutant animals were sick and slow-growing. Thus, we explored the role of sulp-4 in development and embryonic viability. To test the impact of sulp-4 loss of function on developmental rate, we synchronized WT, sulp-4(rae319), and sulp-4(rae334) animals at the first stage of larval development and assayed their growth after 72 hours. We found that sulp-4(rae334) animals displayed a severe developmental delay compared to the wild type (Fig 2D and 2E). Interestingly, sulp-4(rae319) animals showed a more subtle developmental delay (Fig 2D and 2E). Thus, we propose that sulp-4(rae334) is a null allele while sulp-4(rae319) represents a hypomorph. Similarly, we observed that sulp-4(rae334) caused 18% embryonic lethality while sulp-4(rae319) caused 5% embryonic lethality. No embryonic lethality was observed for WT C. elegans (Fig 2F). Thus, we conclude that rae334 and rae319 represent an allelic series for sulp-4 and that sulp-4 is necessary for promoting embryonic and larval development in C. elegans.
pnp-1 was necessary for the formation of xanthine stones in xdh-1; sulp-4 mutant animals
To further test the model that the autofluorescent stones observed in xdh-1; sulp-4 mutant animals were composed of xanthine, we performed genetic epistasis with a null mutation in purine nucleoside phosphorylase (pnp-1), a gene necessary for the formation of hypoxanthine and xanthine (Fig 1A) [25]. PNP-1 is expressed and acts in the C. elegans intestine in addition to expression in some head neurons [25]. As previously observed, xdh-1; sulp-4 double mutant animals displayed 98% autofluorescent stone formation while pnp-1 xdh-1; sulp-4 triple mutant C. elegans displayed 3% formation of autofluorescent stones (Fig 3A). Thus, pnp-1 was necessary for the formation of the autofluorescent stones observed in xdh-1; sulp-4 double mutant animals. Given that pnp-1 plays a conserved role in the formation of hypoxanthine and xanthine, these results support our model that the autofluorescent stones we observe are likely to be predominantly composed of xanthine. Although, we cannot exclude the possibility that other metabolites, such as hypoxanthine, are also present in the autofluorescent stones.
(A) Double and triple mutant Caenorhabditis elegans were assessed for xanthine stone formation when cultured on wild-type (WT) Escherichia coli. ****p < 0.0001, ordinary one-way ANOVA. Individual data points represent biological replicates. Mean and standard deviation are displayed. Complete information regarding sample size and individuals scored per biological replicate is found in S2 Table. (B and C) pnp-1(jy121), sulp-4(rae319), and pnp-1(jy121); sulp-4(rae319) mutant C. elegans were synchronized at the first stage of larval development and cultured for 72 hours on WT E. coli. Animal length and developmental stage were determined. (B) Individual datapoints are displayed as are the mean and standard deviation. The sample size is 15 individuals per genotype. ****p < 0.0001 or ns, p > 0.05, ordinary one-way ANOVA. (C) Sample size is the individuals assayed and is displayed above the bar graph for each genotype.
To determine if pnp-1 acts in a genetic pathway with sulp-4, we tested the impact of pnp-1 loss of function on the developmental delay displayed by sulp-4 mutant animals. pnp-1; sulp-4 double mutant larvae developed at a rate similar to sulp-4 single mutant animals (Fig 3B and 3C). Importantly, pnp-1 mutant animals displayed healthy larval development (Fig 3B and 3C). Thus, pnp-1 was not required for the developmental delay displayed by sulp-4 mutant C. elegans. We propose a genetic pathway where pnp-1 promotes the formation of xanthine stones epistatic to the function of xdh-1 and in parallel to the activity of sulp-4.
sulp-4/SLC26 encodes a sulfate permease that acted in the excretory cell to promote xanthine homeostasis
sulp-4 encodes a transmembrane transporter with homology to the SLC26 family of anion transporters in mammals [13,26]. The C. elegans genome encodes eight members of the SLC26 transporter family, named SULP-1 through SULP-8 [13]. We wondered if other members of the SLC26 family of transporters also played a role in limiting the formation of xanthine stones. To test this, we cultured strains with deletions in sulp-1, sulp-2, sulp-4, sulp-5, sulp-7, and sulp-8 on Moco− E. coli and assayed the formation of xanthine stones. sulp-3 and sulp-6 mutant strains were not analyzed as they are inviable. Only the strain carrying the sulp-4 mutation displayed a high penetrance of xanthine stones (88%, S2B Fig). Thus, the enhancement of xanthine stone formation is specific to loss of sulp-4 and not a general feature of sulp inactivation.
SULP-4 is expressed in the apical membrane of the C. elegans excretory cell, a single cell that plays roles in ionic regulation and waste elimination analogous to the mammalian renal system [13,14,27]. Studies of SULP-4 expressed in Xenopus oocytes demonstrate that SULP-4 is sufficient to promote the transport of sulfate and, to a lesser extent, chloride [13]. To determine the site of action of sulp-4 with respect to the xanthine stone formation phenotype, we generated transgenic xdh-1; sulp-4 double mutant C. elegans expressing a Psulp-4::SULP-4::GFP translational fusion transgene (plasmid was a gift from Dr. Keith Nerhke) [13]. Consistent with previous reports, we exclusively saw expression of the Psulp-4::SULP-4::GFP translational fusion in the excretory cell (Fig 4A and 4B). To test the functionality of the Psulp-4::SULP-4::GFP transgene, we performed rescue experiments with xdh-1; sulp-4 double mutant animals expressing Psulp-4::SULP-4::GFP and assaying the formation of xanthine stones. xdh-1; sulp-4 double mutant animals expressing Psulp-4::SULP-4::GFP did not develop xanthine stones, demonstrating functional transgenic rescue. This rescue was observed in three independently derived transgenic strains (Fig 4C). Thus, the Psulp-4::SULP-4::GFP transgenic fusion protein was functional, suggesting that its expression pattern faithfully represents endogenous SULP-4 localization. We conclude that SULP-4 acts in the excretory cell to negatively regulate the formation of xanthine stones. Our observation that xdh-1; sulp-4 double mutant animals develop xanthine stones in the intestinal lumen suggests that sulp-4 is functioning cell nonautonomously to limit the formation of xanthine stones.
(A and B) Differential interference contrast (left) and fluorescence imaging (right) of xdh-1(ok3234); sulp-4(rae319) Caenorhabditis elegans expressing the Psulp-4::SULP-4::GFP transgene (SULP-4::GFP). The yellow plus sign identifies the cell body of the excretory cell. The red arrow indicates the region magnified in panel B. The yellow asterisk identifies the lumen of the excretory cell. Scale bars are 100 μm (A, top) and 5 μm (B, bottom). (C) Transgenic xdh-1(ok3234); sulp-4(rae319) C. elegans expressing the Psulp-4::SULP-4::GFP transgene (green) and their nontransgenic siblings (black) were assessed for the formation of xanthine stones. Individual data points represent biological replicates. Mean and standard deviation are displayed. ****p < 0.0001, multiple unpaired t tests. Complete information regarding sample size and individuals scored per biological replicate is found in S2 Table.
To further test the role of the excretory cell in preventing the formation of xanthine stones, we used an exc-5 mutation that causes defects in excretory cell development and morphology [28]. We reasoned a malformed excretory cell may not function efficiently and thus phenocopy sulp-4 loss of function with respect to xanthine stone formation. Indeed, exc-5; xdh-1 double mutant animals displayed enhanced formation of xanthine stones (S3A Fig). Although the xanthine stone penetrance of the exc-5; xdh-1 (17%) double mutant strain was modest compared to xdh-1; sulp-4. Importantly, sulp-4 loss of function did not cause cysts in the excretory cell tubules, a severe defect in excretory cell morphology caused by exc-5 loss of function (S3B–S3D Fig). Although we cannot exclude a subtle defect in excretory cell tubule extension in sulp-4 mutant animals. We conclude that the enhancement of xanthine stone formation caused by inactivating mutations in sulp-4 result from loss of SULP-4 anion exchange function and not broader defects in excretory cell biology.
Furthermore, ion homeostasis plays a key role in the defecation cycle which promotes waste elimination from the C. elegans intestine [29]. We wondered if the enhanced formation of xanthine stones observed in xdh-1; sulp-4 animals might result from failures in defecation, leading to xanthine accumulation in the intestinal lumen and xanthine stone formation. To test this model, we used the aex-5(sa23) mutation which causes defects in anterior body-wall muscle contraction (aBoc) and waste expulsion (Exp), critical aspects of the defecation cycle [30]. Interestingly, aex-5; xdh-1 double mutant animals did not display an increased penetrance of xanthine stone formation (S3A Fig). These results suggest that defects in defecation alone are not sufficient to promote xanthine stone accumulation.
cth-2 and cdo-1 were necessary for sulp-4 mutant phenotypes
sulp-4 inactivation caused xanthine stone formation during dietary Moco deficiency (S2A and S4 Fig), demonstrating that the enhancement of xanthine stones caused by sulp-4 loss of function occurs even when endogenous Moco biosynthesis is functional. To test the impact of a sulp-4 mutation on xanthine stone formation during complete Moco deficiency, we engineered sulp-4; cdo-1 moc-1 triple mutant C. elegans that cannot synthesize their own Moco (caused by moc-1 mutation) and are viable during Moco deficiency (caused by cdo-1 suppressor mutation) (Fig 1A). When cultured on Moco− E. coli, sulp-4; cdo-1 moc-1 triple mutants are completely Moco deficient yet only displayed 9% penetrance of xanthine stones (S4 Fig). Similarly, sulp-4; cdo-1 double mutant animals cultured on Moco− E. coli displayed 0% penetrance of xanthine stones, dramatically reduced compared to the 86% penetrance displayed by sulp-4 mutant animals cultured on Moco− E. coli (S4 Fig). These results were surprising and suggest that cdo-1 is necessary for the formation of xanthine stones caused by a sulp-4 mutation and Moco deficiency.
To further test the impact of cdo-1 on the formation of xanthine stones, we engineered xdh-1; sulp-4; cdo-1 triple mutant C. elegans. Surprisingly, xdh-1; sulp-4; cdo-1 triple mutant animals displayed a 5% xanthine stone penetrance, dramatically reduced when compared to the 98% penetrance displayed by xdh-1; sulp-4 double mutant animals (Fig 5A). Thus, cdo-1 was necessary for the formation of xanthine stones displayed by xdh-1; sulp-4 double mutant animals. Interestingly, we still observe a low penetrance of xanthine stones in xdh-1; sulp-4; cdo-1 triple mutant C. elegans suggesting that cdo-1 activity is not absolutely required for the formation of xanthine stones but only required for the xanthine stone enhancement caused by sulp-4 loss of function.
(A) Double and triple mutant Caenorhabditis elegans were assessed for xanthine stone formation when cultured on wild-type (WT) Escherichia coli over the first 3 days of adulthood. Individual data points represent biological replicates. Mean and standard deviation are displayed. ****p < 0.0001, ordinary one-way ANOVA. Complete information regarding sample size and individuals scored per biological replicate is found in S2 Table. (B) Triple mutant C. elegans exposed to 0 or 1.5 mM supplemental cysteine were assessed for xanthine stone formation when cultured on WT E. coli over the first 2 days of adulthood. Mean and standard deviation are displayed. *p < 0.05 and ns, p > 0.05, multiple unpaired t tests. Complete information regarding sample size and individuals scored per biological replicate is found in S2 Table. (C and D) WT and mutant C. elegans were synchronized at the first stage of larval development and cultured for 72 hours on WT E. coli. Animal length and developmental stage were determined. (C) Individual datapoints are displayed as are the mean and standard deviation. The sample size is 15 individuals per genotype. ****p < 0.0001, ordinary one-way ANOVA. (D) Sample size is the individuals assayed and is displayed above the bar graph for each genotype. (E) The hatching rate of newly laid single and double mutant C. elegans embryos was determined. Individual data points represent biological replicates. Mean and standard deviation are displayed. **p < 0.01 or *p < 0.05, ordinary one-way ANOVA. Complete information regarding sample size and individuals scored per biological replicate is found in S2 Table. The sulp-4(rae334) allele was used to generate the data in Fig 5.
cdo-1 encodes the C. elegans cysteine dioxygenase, a critical enzyme in the sulfur amino acid catabolism pathway that breaks down excess cysteine and methionine (Fig 1A) [8,31,32]. To determine if the impact of cdo-1 on the enhanced xanthine stone formation caused by sulp-4 inactivation was a result of impaired sulfur amino acid catabolism, we used a cth-2 mutation which eliminates the activity of C. elegans cystathionase (Fig 1A). Consistent with our results with cdo-1 loss of function, we found that cth-2; xdh-1; sulp-4 triple mutant animals also displayed a low 19% penetrance of xanthine stones (Fig 5A). Taken together, these genetic data suggest that sulfur amino acid catabolism is required for the enhancement of xanthine stone accumulation caused by loss of sulp-4 function.
Given that sulp-4 encodes a sulfate permease, we hypothesized that sulfate accumulation during sulp-4 loss of function was promoting the formation of xanthine stones. Furthermore, we hypothesized that this sulfate was produced endogenously via CTH-2 and CDO-1. To further test this model, we measured sulfur content in large cultures of WT and sulp-4 mutant C. elegans using inductively coupled plasma mass spectrometry (ICP-MS). We did not observe any difference in sulfur content between WT and sulp-4 mutant animals, demonstrating that sulp-4 mutant C. elegans do not accumulate sulfur (S5B Fig). Similarly, we saw no difference in K, Fe, Zn, Mn, Cu, or Mo content between wild-type and sulp-4 mutant animals (S5 Fig). A key limitation of this method is that ICP-MS does not distinguish between sulfur found in different metabolites, such as sulfate, sulfite, methionine, cysteine, etc. Thus, it is plausible that sulp-4 mutant animals accumulate sulfate with a corresponding decrease in another sulfur-containing metabolite. Alternatively, sulfate sulfur may only account for a small fraction of the animal sulfur economy. Thus, physiologically significant changes in sulfate may be undetectable given the high background of sulfur found in more common metabolites like cysteine or methionine.
To further test the relationship between sulfur amino acid catabolism and xanthine stone formation, we supplemented xdh-1; sulp-4; cdo-1 or cth-2; xdh-1; sulp-4 triple mutant C. elegans with the sulfur-containing amino acid cysteine and assessed the impact on xanthine stone formation. Cysteine supplementation is informative as it is the product of CTH-2 and the substrate for CDO-1 (Fig 1A). We found that cysteine promoted xanthine stone formation in cth-2; xdh-1; sulp-4 animals, bypassing the requirement for cth-2. Alternatively, cysteine did not promote xanthine stones in xdh-1; sulp-4; cdo-1 mutant animals, demonstrating that cdo-1 was necessary for cysteine to promote xanthine stone formation (Fig 5B). This result supports our model that endogenous sulfur amino acid catabolism promotes xanthine stone formation. More specifically, these data demonstrate that a cysteine-derived metabolite downstream of CDO-1 is acting to promote xanthine stones. This is consistent with our model that sulfate accumulation during sulp-4 loss of function promotes xanthine stone accumulation.
To test whether mutations in cth-2 or cdo-1 would suppress the defects in larval and embryonic development displayed by sulp-4 mutant animals, we assayed larval and embryonic development in cth-2; sulp-4 and sulp-4; cdo-1 double mutant animals and compared to sulp-4 single mutant animals. Consistent with their suppression of xanthine stone formation, cth-2 or cdo-1 mutations suppressed the developmental delay and embryonic lethality caused by a sulp-4 mutation (Fig 5C–5E). Thus, we conclude that cth-2 and cdo-1 are broadly required for phenotypes caused by sulp-4 loss of function.
Loss of osm-8 promoted xanthine stone accumulation in xdh-1 mutant animals, linking osmotic homeostasis and xanthine stone formation
What is the mechanism by which sulfates, derived from CTH-2 and CDO-1, might promote xanthine stone formation when sulp-4 is inactivated? Given that sulp-4 encodes a sulfate permease that functions in the C. elegans excretory cell, we hypothesized that sulp-4 mutant animals may be experiencing osmotic imbalance driven by excess sulfate. Supporting this model, sulp-4 mutant animals accumulated 25% more sodium than their WT counterparts as measured by ICP-MS (Fig 6A). These data demonstrate that sulp-4 mutant animals are experiencing osmotic imbalance.
(A) Sodium content was determined for synchronized wild-type (WT) and sulp-4(rae319) young adult C. elegans using ICP-MS. Individual data points represent biological replicates. Mean and standard deviation are displayed. *p < 0.05, t test. (B) Survival of WT, sulp-4(rae319), xdh-1(ok3234), or osm-8(n1518) young adult C. elegans was determined after 24-hour exposure to nematode growth media containing various concentrations of NaCl. Mean and standard deviation of 3 biological replicates are displayed. Complete information regarding sample size and individuals scored per biological replicate is found in S2 Table. (C) Mutant C. elegans were assessed for xanthine stone formation when cultured on WT Escherichia coli. Individual data points represent biological replicates. Mean and standard deviation are displayed. ***p < 0.001, **p < 0.01, *p < 0.05, ordinary one-way ANOVA. Complete information regarding sample size and individuals scored per biological replicate is found in S2 Table. (D) Relative mRNA levels of cdo-1 are displayed for RNA isolated from WT, sulp-4(rae319), and osm-8(n1518) young adult C. elegans. Relative mRNA abundance was determined via the delta-delta CT method. All transcripts are normalized to act-1. Relative mRNA abundance for each transcript was set to one in the wild type. ****p < 0.0001, **p < 0.01, ordinary one-way ANOVA.
To test the model that osmotic imbalance promotes the formation of xanthine stones, we challenged xdh-1 mutant animals with supplemental NaCl. Interestingly, xdh-1 mutant animals were extremely sensitive to high environmental NaCl when compared to wild type, a phenotype also displayed by rats lacking xdh-1 (Fig 6B) [33]. These data indicate a conserved role for xdh-1 in promoting hyperosmotic stress tolerance. However, the sensitivity of xdh-1 mutant C. elegans to NaCl limited our ability to directly test whether hyperosmotic stress promotes xanthine stone formation in an xdh-1 mutant background.
To genetically test whether osmotic imbalance may promote xanthine stones, we used a loss-of-function mutation in osm-8 that constitutively activates the hyperosmotic stress response in the absence of environmental osmotic stress [15,34]. osm-8 encodes a mucin-like protein and is expressed in the C. elegans hypodermis [15]. Interestingly, osm-8; xdh-1 double mutant C. elegans developed xanthine stones like xdh-1; sulp-4 double mutant animals (Fig 6C). Although, the xanthine stones observed in osm-8; xdh-1 double mutant animals were not as large as those observed in xdh-1; sulp-4 animals (S1 Fig). Furthermore, like xdh-1; sulp-4 double mutant C. elegans, cdo-1 was necessary for the formation of xanthine stones in osm-8; xdh-1 double mutant animals (Fig 6C). However, it should be noted that cdo-1 loss of function incompletely suppressed the formation of xanthine stones in osm-8; xdh-1 mutant animals, suggesting additional pathways downstream of osm-8 that govern xanthine stone formation. These data suggest that altered osmotic homeostasis, driven by osm-8 loss of function, is sufficient to cause xanthine stone accumulation when XDH-1 is inactive.
We wondered if sulp-4 and osm-8 mutant animals display additional overlapping phenotypes. osm-8 mutant C. elegans are resistant to high NaCl stress and display increased transcription of the hypertonic stress response which includes the key regulators of osmolyte accumulation, gpdh-1 and hmit-1.1 [15,34]. gpdh-1 encodes glycerol 3-phosphate dehydrogenase and is required to produce glycerol, a critical osmolyte [35,36]. hmit-1.1 encodes an H+/myo-inositol transporter and functions to import myo-inositol, another important osmolyte [37]. Distinct from osm-8 mutant animals, sulp-4 mutant C. elegans were not resistant to high NaCl (Fig 6B). Furthermore, sulp-4 mutant animals did not significantly accumulate hmit-1.1 mRNA and modestly accumulated gpdh-1 mRNA when compared to the wild type (S6A and S6B Fig). These data suggest that sulp-4 inactivation does not robustly activate transcription of all canonical hypertonic stress response genes. Interestingly, both sulp-4 and osm-8 mutant animals accumulated cdo-1 mRNA when compared to the wild type (Fig 6D), consistent with previous studies in C. elegans and mammals that demonstrate cdo-1 induction by osmotic imbalance (high NaCl exposure or osm-8 inactivation) [34,38]. Taken together, these data highlight overlapping but distinct phenotypic profiles for sulp-4 and osm-8 mutant C. elegans and elucidate a positive feedback loop connecting sulp-4, osmotic imbalance, and cdo-1 activation.
In addition to its role in cysteine catabolism, CDO-1 is also essential for synthesis of the osmolyte taurine [32,38]. Given that cdo-1 was necessary for phenotypes caused by sulp-4 inactivation, we wondered whether inactivating mutations in other genes involved in osmolyte accumulation may also suppress sulp-4 mutant phenotypes. To test this, we engineered gpdh-1; sulp-4 and hmit-1.1; sulp-4 double mutant strains of C. elegans and assayed for the formation of xanthine stones when animals were cultured on a Moco− diet. Unlike cdo-1, neither gpdh-1 nor hmit-1.1 was necessary for the formation of xanthine stones caused by a sulp-4 mutation (S6C Fig). These data suggest that the suppression of sulp-4 mutant phenotypes by cdo-1 loss-of-function is specific and not a general feature of inactivating mutations in genes involved in the osmotic stress response. However, it is important to note that the C. elegans genome encodes homologs of both gpdh-1 and hmit-1.1 which may act redundantly, complicating the mechanistic interpretation of these genetic data [35].
We propose the model that in healthy WT C. elegans, cysteine and methionine are being broken down by the sulfur amino acid catabolism pathway (CTH-2/CDO-1), maintaining sulfur homeostasis. This results in the production of sulfate which is exported into the environment via the action of SULP-4 in the excretory cell. However, when sulp-4 is inactive, sulfate cannot be safely excreted and accumulates. This issue is exacerbated by an induction of cdo-1 mRNA during sulp-4 loss of function. This creates a maladaptive positive feedback loop that we anticipate would further increase sulfate production. We speculate that sulfate accumulation then promotes osmotic imbalance which causes embryonic lethality, impaired larval development, and an increased propensity to form xanthine stones when xdh-1 is inactive (Fig 7).
In wild-type C. elegans, sulfur amino acid catabolism gives rise to sulfate which is maintained at homeostatic levels by SULP-4-mediated exchange with the environment via the excretory cell. During sulp-4 loss of function, CTH-2/CDO-1-derived sulfates accumulate causing osmotic imbalance. This osmotic imbalance promotes a maladaptive positive feedback loop promoting additional cdo-1 mRNA accumulation. This cascade culminates in embryonic lethality, altered larval development, and a propensity to form xanthine stones when XDH-1 activity is compromised.
Discussion
Modeling xanthinuria in C. elegans
Human xanthinuria was originally described in 1954, and presents with high urinary xanthine, low uric acid in serum and urine, the formation of xanthine stones, and, in some cases, renal failure [5,39]. Still, there are no curative treatments for xanthinuria or the formation of xanthine stones. The current recommendation for patients is a high fluid intake and low purine diet [7]. Thus, understanding the cellular mechanisms that regulate the pathology associated with xanthinuria is an important goal.
Animal models, such as C. elegans, are powerful tools for exploring the pathology of rare inborn errors of metabolism, including NGLY1 deficiency, Moco deficiency, Friedrich’s ataxia, and many others [8,40,41]. Here, we used C. elegans to model human type I and type II xanthinuria. We employed genetic strategies to inhibit XDH-1 activity by mutating the xdh-1 gene (type I) or limiting animal Moco (type II) [4,5]. Both manipulations recapitulated a critical feature of human XDH deficiency, the formation of insoluble xanthine stones.
Interestingly, xanthine stones are highly autofluorescent and visible with a standard fluorescence microscope, a phenotype that has been previously characterized in the model plant Arabidopsis thaliana [18]. Given the transparent nature of C. elegans, this phenotype empowers genetic analyses of xanthine stone accumulation and, by proxy, purine biology. Here, we used the power of C. elegans genetics in combination with this simple phenotype to identify and characterize regulators of purine homeostasis.
Defining genetic regulators of xanthine stone formation
We sought to define genetic regulators of the formation of xanthine stones. Given the established purine catabolism pathway (Fig 1A), we used a hypothesis-driven approach to define genes that regulate the formation of xanthine stones. Purine nucleoside phosphorylase (PNP-1/PNP) was a lead candidate given its biochemical requirement for the formation of xanthine. Indeed, we demonstrated that pnp-1 was necessary for the formation of xanthine stones in our C. elegans mutant animals: pnp-1 loss of function suppressed the formation of xanthine stones in an xdh-1; sulp-4 double mutant background. These results suggest that inhibiting the activity of PNP may be a therapeutic strategy for limiting the accumulation of xanthine and xanthine stones in patients suffering from xanthinuria. However, this treatment strategy may be fraught, given the consequences of PNP inactivation. Human patients with PNP deficiency display impaired T-cell immunity [3]. In fact, a potent PNP inhibitor has been developed, and induces apoptosis of B- and T-lymphocytes [42,43]. Thus, the potential benefits of PNP inhibition in the treatment of human xanthinuria patients would need to be evaluated and weighed against the negative impacts on the immune system.
To identify new and unexpected regulators of purine homeostasis, we employed an unbiased genetic approach. In a forward genetic screen, we identified sulp-4 as a potent modifier of xanthine stone formation. Loss-of-function mutations in sulp-4 dramatically enhanced the penetrance and expressivity of xanthine stone formation in our C. elegans models of xanthinuria. Interestingly, we also found that sulp-4 was necessary for promoting normal larval and embryonic development. These genetic data demonstrate that sulp-4 promotes healthy development and acts in a parallel pathway to xdh-1 to limit the accumulation of xanthine stones.
sulp-4 was previously demonstrated to encode a sulfate permease that localizes to the apical membrane of the excretory cell, which we also observed [13]. Importantly, we demonstrated that Psulp-4::SULP-4::GFP rescued the formation of xanthine stones displayed by an xdh-1; sulp-4 double mutant animal. This functional rescue is strong evidence that sulp-4 is acting in the excretory cell to limit the formation of xanthine stones. Interestingly, xanthine stones accumulate in the lumen of the C. elegans intestine while sulp-4 acts in the excretory cell. Thus, we conclude that sulp-4 acts cell-nonautonomously to limit xanthine stone accumulation. These data establish a new intersection between SULP-4, the excretory cell, and purine homeostasis.
Linking osmotic homeostasis and xanthine stone formation
We next sought to understand the nature of the genetic interaction between sulp-4 and xdh-1 with respect to xanthine stone formation. Given that sulp-4 encodes a sulfate transporter that acts cell-nonautonomously in the excretory cell, we hypothesized that sulp-4 mutations may cause sulfate retention and disturb osmotic balance in C. elegans systemically [13]. Indeed, we found that sulp-4 mutant C. elegans accumulated sodium, demonstrating osmotic imbalance [44,45]. Importantly, we do not know the site of excess sodium accumulation (cellular versus extracellular) in sulp-4 mutant C. elegans. We propose the model that osmotic imbalance in sulp-4 mutant animals is driven by a failure to excrete endogenously produced sulfates. This model is supported by our genetic demonstration that cth-2 or cdo-1, genes that encode enzymes necessary for sulfate production, were necessary for xanthine stone formation in xdh-1; sulp-4 mutant animals. We speculate that osmotic imbalance driven by sulfate retention may promote water reabsorption causing dehydration in the intestinal lumen, increasing xanthine concentration and stone formation. This model is reinforced by our observation that activation of the hyperosmotic stress response through a distinct genetic perturbation, osm-8 loss of function, also promoted the formation of xanthine stones in an xdh-1 mutant background [15]. In the case of osm-8 inactivation, we speculate that glycerol accumulation would drive water reabsorption and dehydration in the intestinal lumen. Again, this dehydration would increase xanthine concentration, promoting stone formation.
Intersection between sulfur amino acid metabolism and Moco-dependent metabolism
Previous studies in C. elegans identified cth-2 and cdo-1 loss-of-function mutations as suppressors of the lethality associated with Moco deficiency and deficiency of the Moco-requiring enzyme sulfite oxidase [8]. Loss of sulfite oxidase is lethal in C. elegans and humans due to the accumulation of its reactive and toxic substrate, sulfite (Fig 1A) [8,46]. cth-2 and cdo-1 inactivation limit the accumulation of sulfites, suppressing the lethality caused by Moco or sulfite oxidase deficiency. Is it a coincidence that loss of cth-2 or cdo-1 suppress phenotypes associated with two distinct Moco-requiring enzymes: i) lethality displayed by suox-1 null mutant animals and ii) xanthine stone formation of xdh-1; sulp-4 double mutant animals? Given that the substrates and products of these two Moco-dependent enzymes are distinct, it is peculiar that loss-of-function phenotypes of both are modulated by these common genetic factors. Future studies are required to tease apart the potential molecular intersections between CTH-2/CDO-1 and these Moco-dependent pathways.
An additional layer of complexity is added when considering the regulation of cdo-1. Here, we reinforce previous observations that cdo-1 is activated in response to hyperosmotic stress [34,38]. sulp-4 and osm-8 mutant C. elegans both accumulated cdo-1 mRNA. Yet, CDO-1/CDO levels and activity are also modified by dietary sulfur amino acid content. This regulation includes both transcriptional and post-translational control of cysteine dioxygenase [31,47–51]. Given that SULP-4 mediates sulfate transport and sulfate is a metabolic product of sulfur amino acid catabolism governed by CTH-2/CDO-1/SUOX-1, sulfate seems like a potential metabolic intersection between these seemingly disparate Moco-dependent pathways. Whether there is any overlap between the mechanisms of CDO-1/CDO regulation downstream of hyperosmotic stress and high sulfur amino acid content remains to be studied.
SULP-4 homologs are implicated in calcium oxalate stone formation
Our genetic studies demonstrate that SULP-4 plays a role in limiting the formation of xanthine stones in C. elegans models of xanthinuria. SULP-4 is homologous to human SLC26 proteins which have been previously linked to metabolic stone formation. Understanding the connection between SLC26 proteins, like SULP-4, and the formation of metabolic stones is important as 1 out of every 10 individuals in the United States will develop a kidney stone over the course of their lifetime [52]. For instance, mouse SLC26A6 limits urolithiasis, paralleling our results with C. elegans SULP-4. Specifically, SLC26A6 null mutant mice develop a high incidence of calcium oxalate stones in the bladder [53]. Similarly, a dominant negative mutation in SLC26A6 and loss-of-function mutations in SLC26A1 are proposed to cause calcium oxalate nephrolithiasis in humans [54,55]. In contrast, the Drosophila melanogaster homolog of human SLC26A5/6, dPrestin, promotes the formation of calcium oxalate stones in the Malpighian tubules in a dietarily-induced model of calcium oxalate nephrolithiasis. Under a diet of high oxalate, Drosophila develop calcium oxalate stones whose formation is dampened by RNAi knockdown of dPrestin [56]. With respect to calcium oxalate stones, the mechanism of stone formation is believed to relate directly to the role of the SLC26 family members in oxalate transport. Loss of SLC26 proteins results in higher or lower concentrations of oxalate in a given space, altering the likelihood of stone formation. We propose that xanthine is the critical component of the stones that form in xdh-1; sulp-4 mutant animals, not oxalate. In heterologous transport assays, oxalate was not meaningfully transported by SULP-4 [13]. However, it is possible that sulp-4 mutations may enhance the formation of additional metabolic stones given a specific genetic or environmental perturbation. This hypothesis remains to be tested. Regardless, we think it is very intriguing that SLC26 homologs in mouse, humans, flies, and worms have all been shown to play roles in metabolic stone formation and suggest the potential for a fundamental mechanism underlying these discrete observations.
Materials and methods
General methods and strains
C. elegans were cultured using established protocols [22]. Briefly, animals were cultured at 20 °C on nematode growth media (NGM) seeded with WT E. coli (OP50) unless otherwise noted. The WT strain of C. elegans was Bristol N2. Additional E. coli strains used in this work were BW25113 (Wild type, Moco+) and JW0764-2 (ΔmoaA753::kan, Moco−) [57].
C. elegans mutant and transgenic strains used in this work are listed here. When previously published, sources of strains are referenced. Unless a reference is provided, all strains were generated in this study.
Non-transgenic strains.
- N2, wild type [22]
- GR2257, cth-2(mg599) II [8]
- GR2259, cth-2(mg599) II; moc-1(ok366) X [8]
- GR2260, cdo-1(mg622) [8]
- GR2261, cdo-1(mg622) moc-1(ok366) X [8]
- USD869, xdh-1(ok3234) IV (Outcrossed 2X)
- USD1033, sulp-4(rae319) V (Outcrossed 4X)
- USD1037, sulp-4(rae319) V; cdo-1(mg622) moc-1(ok366) X
- USD1038, sulp-4(rae319) V; cdo-1(mg622) X
- USD1055, xdh-1(ok3234) IV; sulp-4(rae334) V
- USD1091, sulp-4(rae334) V; cdo-1(mg622) X
- USD1103, cth-2(mg599) II; sulp-4(rae334) V
- USD1105, cth-2(mg599) II; xdh-1(ok3234) IV; sulp-4(rae334) V
- USD1146, xdh-1(ok3234) IV; sulp-4(rae334) V; cdo-1(mg622) X
- USD1154, xdh-1(ok3234) IV; cdo-1(mg622) X
- USD1163, pnp-1(jy121) IV (Outcrossed 1X) [25]
- USD1170, cth-2(mg599) II; xdh-1(ok3234) IV
- USD1174, pnp-1(jy121) xdh-1(ok3234) IV
- USD1198, pnp-1(jy121) IV; sulp-4(rae319) V
- USD1215, pnp-1(jy121) xdh-1(ok3234) IV; sulp-4(rae319) V
- USD1230, aex-5(sa23) I; xdh-1(ok3234) IV
- USD1269, exc-5(rh232) xdh-1(ok3234) IV
- USD1308, osm-8(n1518) II; xdh-1(ok3234) IV
- USD1310, gpdh-1(ok1558) I (Outcrossed 4X)
- USD1312, hmit-1.1(ok2923) V (Outcrossed 4X)
- USD1322, gpdh-1(ok1558) I; sulp-4(rae319) V
- USD1324, sulp-4(rae319) hmit-1.1(ok2923) V
- USD1327, osm-8(n1518) II; xdh-1(ok3234) IV; cdo-1(mg622) X
- JT23, aex-5(sa23) I [30]
- NJ731, exc-5(rh232) IV [28]
- MT3571, osm-8(n1518) II [15]
- RB1082, sulp-5(ok1048) V
- RB1366, sulp-2(ok1551) X
- RB1369, sulp-2(ok1554) X
- RB1436, sulp-1(ok1639) I
- RB2134, sulp-8(ok2842) V
- FX08263, sulp-5(tm8264) X
- VC3021, sulp-7(ok3751) X
- VC3045, sulp-7(ok3752) X
Transgenic strains.
- USD1060, xdh-1(ok3234) IV; sulp-4(rae319) V; raeEx118
- USD1061, xdh-1(ok3234) IV; sulp-4(rae319) V; raeEx119
- USD1062, xdh-1(ok3234) IV; sulp-4(rae319) V; raeEx120
- USD1251, qpIs11 I; sulp-4(rae319) V
- USD1277, qpIs11 I; exc-5(rh232) IV
- BK36, qpIs11 I; unc-119(ed3) III [58]
EMS-derived strains.
- USD962*, xdh-1(ok3234) IV; sulp-4(rae299) V
- USD1007, xdh-1(ok3234) IV; sulp-4(rae299) V (Outcrossed 2X)
- USD971*, xdh-1(ok3234) IV; sulp-4(rae302) V
- USD997, xdh-1(ok3234) IV; sulp-4(rae302) V (Outcrossed 1X)
- USD990*, xdh-1(ok3234) IV; sulp-4(rae319) V
- USD1001, xdh-1(ok3234) IV; sulp-4(rae319) V (Outcrossed 1X)
- USD1013*, xdh-1(ok3234) IV; sulp-4(rae320) V
- USD1019*, xdh-1(ok3234) IV; sulp-4(rae326) V
*Whole genome sequencing data for these C. elegans strains have been deposited at the NIH Sequence Read Archive (SRA) under accession PRJNA1208078.
CRISPR/Cas9-derived strains.
- USD1042, sulp-4(rae334) V
Chemical mutagenesis and whole genome sequencing
To define C. elegans gene activities that were necessary for promoting purine homeostasis, we carried out a chemical mutagenesis screen for mutations that enhanced the penetrance of xanthine stone formation in xdh-1(ok3234) mutant C. elegans (USD869). C. elegans were mutagenized with ethyl methanesulfonate (EMS) using established protocols [22]. Over multiple rounds of mutagenesis, we surveyed ~100,000 mutagenized haploid genomes. To increase the likelihood of identifying a mutation that enhanced xanthine stone formation, we cloned ~600 F2 generation animals that displayed a xanthine stone onto individual NGM petri dishes. F3 generation animals from these ~600 isolates were then screened qualitatively for a population-level increase in xanthine stone penetrance. We demanded that new mutant strains of interest were viable and fertile.
Here, we report the analysis of 5 new mutant strains (USD962, USD971, USD990, USD1013, and USD1019). Each of these strains carried new EMS-induced lesions (rae299, rae302, rae319, rae320, or rae326) that enhanced the formation of xanthine stones in an xdh-1 mutant background. Each mutation was recessive; when heterozygous, each lesion caused 5% (rae302, n = 42 individuals), 0% (rae319, n = 38 individuals), 2% (rae299, n = 41 individuals), or 5% (rae326, n = 22 individuals) xanthine stone formation in an xdh-1 mutant background, dramatically reduced when compared to their homozygous counterparts (Fig 2B). rae320 was never characterized as dominant or recessive.
To further genetically analyze these lesions, we performed complementation analyses of these new mutations. The rae319 lesion failed to complement rae302 (100% xanthine stone penetrance, n = 71 individuals), rae299 (87% xanthine stone penetrance, n = 38 individuals), and rae326 (100% xanthine stone penetrance, n = 14 individuals). All complementation experiments were performed in an xdh-1(ok3234) homozygous mutant genetic background. These results suggest rae302, rae319, rae299, and rae326 all impact the same gene. Complementation studies were not performed on rae320.
To identify EMS-induced mutations in our strains of interest, we followed established protocols [59]. Briefly, whole genomic DNA was prepared from C. elegans using the Gentra Puregene Tissue Kit (Qiagen) and genomic DNA libraries were prepared using the NEBNext genomic DNA library construction kit (New England Biolabs, MA, USA). DNA libraries were sequenced on an Illumina NovaSeq and deep sequencing reads were analyzed using standard methods on Galaxy, a web-based platform for computational analyses [60]. Briefly, sequencing reads were trimmed and aligned to the WBcel235 C. elegans reference genome [61,62]. Variations from the reference genome and the putative impact of those variations were annotated and extracted for analysis [63–65]. All four strains that formed a complementation group possessed novel mutations in the gene sulp-4, strongly suggesting that these lesions in sulp-4 caused the enhanced xanthine stone formation in the xdh-1 mutant background (Fig 2A and S1 Table). Although the rae320 lesion found in USD1013 was not analyzed via complementation, whole genome sequence analyses identified a homozygous mutation in sulp-4. Thus, we assume that the lesion in sulp-4 found in USD1013 is also causative for the enhanced xanthine stone formation in the xdh-1 mutant background (S1 Table). In fact, rae319 and rae320 are identical genetic lesions. We know that strains carrying these genetic lesions are not siblings as they were derived from independent rounds of mutagenesis. Whole genome sequencing data for these C. elegans strains have been deposited at the NIH SRA under accession PRJNA1208078.
CRISPR/Cas9 genome editing
Genome engineering using CRISPR/Cas9 technology was performed using established techniques [23,24]. Briefly, 2 guide RNAs were designed and synthesized (IDT, crRNA) that targeted the sulp-4 locus (5′-agagttagctttgtacaacg-3′ and 5′-atagcacatgatacttccgt-3′). Cas9 (IDT) guide RNA ribonucleoprotein complexes were directly injected into the C. elegans germline [23]. Newly induced deletions were identified in the offspring of injected animals using a PCR-based screening approach. The DNA primers used to screen for new deletions were: 5′-gcagagaaactcagagcaacaa-3′ and 5′- gcttggtttggaaactttgg-3′. We were able to isolate and homozygoze sulp-4(rae334), a new deletion of sulp-4 (Fig 2A).
C. elegans transgenesis
Transgenic C. elegans carrying extrachromosomal arrays were generated by micro-injecting the gonad of young adult xdh-1(ok3234); sulp-4(rae319) double mutant C. elegans with an injection mix consisting of the Psulp-4::SULP-4::GFP plasmid (20 ng/μl), the Pmyo-2::mCherry co-injection marker (2 ng/μl), and the KB+ ladder (78 ng/μl, New England Biolabs) [66]. Three independently derived transgenic strains carrying the extrachromosomal arrays raeEx118, raeEx119, or raeEx120 were isolated and maintained by propagating individual animals based on expression of the fluorescent mCherry protein in the pharynx.
Determination of xanthine stone penetrance
To determine the percentage of animals that developed a xanthine stone, we cultured WT, mutant, and transgenic C. elegans beginning at the L1 stage of development under various growth conditions. Animals were assessed for the formation of a xanthine stone beginning at the L4 stage. Animals were assessed daily through the first 4 days of adulthood except for experiments that used the cdo-1(mg622) allele or supplemental cysteine where assays were terminated at day 3 or 2 of adulthood, respectively. cdo-1(mg622) and supplemental cysteine caused early lethality that limited the number of individuals that survived per biological replicate. Thus, the assays were shortened to increase the sample size in Figs 1B, 5A, 5B, 6C, and S4. Importantly, all datapoints in a given figure panel were subjected to the same assay conditions and are thus directly comparable. Xanthine stones were determined based upon the presence of exceptionally bright autofluorescent puncta that were opaque when observed by brightfield microscopy. If an individual displayed a stone, it was scored as such and removed from the assay. If an animal did not display a stone, it was counted and moved to a fresh petri dish to prevent contamination from the subsequent generation and allow for assessment on the following day. Thus, if an animal displayed a xanthine stone on any day of the assay, it scored positive and counted towards the penetrance of the phenotype. Xanthine stone penetrance was the percentage of animals that displayed a stone over the course of the assay. If animals went missing or died before the end of the assay, they were not included in the final analyses.
C. elegans larval development and embryonic viability assays
To assay developmental rates, C. elegans were synchronized at the first stage of larval development. To synchronize animals, embryos were harvested from gravid adult animals via treatment with a bleach and sodium hydroxide solution. Embryos were then incubated overnight in M9 solution causing them to hatch and arrest development at the L1 stage [67]. Synchronized L1 animals were cultured for 72 hours under standard conditions, and live animals were imaged as described below. Animal length was measured from tip of head to the end of the tail. To define the rate of progression through C. elegans development, animals were alternatively scored as being younger than L4 (<L4), L4, or young adults.
To determine the hatching rate of WT and mutant C. elegans, we performed synchronized egg lays using young adult animals. Embryos were then scored for hatching ~24 hours after being laid.
Microscopy
Low magnification bright field and fluorescence images (Figs 1C and S1) were collected using a Nikon SMZ25 microscope equipped with a Hamamatsu Orca flash 4.0 digital camera using NIS-Elements software (Nikon). High magnification differential interference contrast (DIC) and GFP fluorescence images (Figs 2C, 4A, 4B, and S3B–S3D) were collected using a Nikon NiE microscope equipped with a Hamamatsu Orca flash 4.0 digital camera using NIS-Elements software (Nikon). Xanthine stones were visualized and imaged using the EGFP BP (FITC/Cy2) HC Filter Set (Nikon). All images were processed and analyzed using ImageJ software (NIH). All imaging was performed on live animals paralyzed using sodium azide.
Quantitative PCR (qPCR)
RNA was extracted from synchronized WT, sulp-4(rae319), and osm-8(n1518) young adult animals using Trizol Reagent per manufacturer’s instructions (Invitrogen). Prior to RNA extraction, live C. elegans samples were washed and subsequently incubated for one hour in buffer M9 to allow for removal of bacterial contamination. cDNA was then synthesized using the GoScript Reverse Transcriptase System following manufacturer’s instructions (Promega). qPCR was performed using a CFX96 Real-Time System (Bio-Rad) and SYBR Green Master Mix following manufacturer’s instructions (Applied Biosystems). Relative mRNA levels were calculated using the comparative CT methods [68]. Forward and reverse amplification primers were act-1, 5′-ctcttgccccatcaaccatg-3′ and 5′-cttgcttggagatccacatc-3′; cdo-1, 5′-ttcgatgagagaaccggaaag-3′ and 5′-gccattcttagatcctctgtagtc-3′; hmit-1.1, 5′-ccattgaagaggtagaaatgc-3′ and 5′-tgtacttcattgtgttgtcc-3′; and gpdh-1, 5′-tgcagagattccaggaaaccagg-3′ and 5′-cccttttgtagcttgccacggag-3′.
Elemental analyses
For elemental analyses (S, K, Na, Mn, Fe, Cu, Zn, and Mo) of WT or sulp-4(rae319) mutant C. elegans, 29.9–34.7 mg of tissue (~20,000 freeze-dried young adult C. elegans) were digested in 200 μl of concentrated HNO3 at 90 °C for 1 hour. After digestion, samples were diluted to a working volume of 1.4 ml and subsequently diluted an additional 5× (Mn, Fe, Cu, Zn, and Mo) or 200× (S, K, and Na) to produce final samples for elemental analysis. All dilutions were performed with 1% HNO3. Inductively coupled plasma mass spectroscopy (ICP-MS) analysis was performed using an Agilent 8900 triple quad equipped with an SPS autosampler. The system was operated at a radio frequency power of 1,550 W, an argon plasma gas flow rate of 15 L/min, and an Ar carrier gas flow rate of 0.9 L/min. Data were quantified using weighed, serial dilutions of a multi-element standard (CEM 2, (VHG Labs, VHG-SM70B-100) K, Na, Mn, Fe, Cu, and Zn) and a single-element standards for S (Spex CertiPrep, PLS9-2M) and Mo (Spex CertiPrep, CLMO9-2Y).
NaCl tolerance assay
To assay NaCl tolerance, WT, xdh-1, sulp-4, or osm-8 mutant C. elegans were synchronized at the first stage of larval development. To synchronize animals, embryos were harvested from gravid adult animals via treatment with a bleach and sodium hydroxide solution. Embryos were then incubated overnight in M9 solution causing them to hatch and arrest development at the L1 stage [67]. Synchronized L1 animals were cultured under standard conditions for 72 hours or until reaching the young adult stage. Young adult animals were then transferred to NGM plates with various NaCl concentrations (50, 200, 300, 400, 500, or 600 mM NaCl). Animals were scored as alive or dead based on touch responsiveness after a 24-hour exposure to the various NaCl conditions. If animals went missing before the end of the assay, they were not included in the final analyses.
Supporting information
S1 Fig. Loss of sulp-4 enhanced the expressivity of the xanthine stone phenotype displayed by xdh-1 mutant animals.
Brightfield (left) and fluorescent (right) images of (A) xdh-1(ok3234), (B) xdh-1(ok3234); sulp-4(rae319), or (C) osm-8(n1518); xdh-1(ok3234) mutant adult C. elegans cultured on wild-type E. coli. Scale bar is 250 μm. Note, xdh-1(ok3234) animals displayed are older than their xdh-1(ok3234); sulp-4(rae319) or osm-8(n1518); xdh-1(ok3234) counterparts which were imaged as day 2 adults. This was necessary to allow us to identify sufficient xdh-1 single mutant animals displaying a xanthine stone.
https://doi.org/10.1371/journal.pbio.3003410.s001
(EPS)
S2 Fig. Inactivating mutations in sulp genes other than sulp-4 did not enhance xanthine stone formation during dietary Moco deficiency.
(A) Wild-type (WT) and sulp-4(rae319) C. elegans were cultured on WT (black, Moco+) or ΔmoaA mutant (red, Moco−) E. coli and assessed for the formation of xanthine stones. Note, data points for the WT animals cultured on Moco+ and Moco− E. coli are derived from the same experiment that is displayed in Fig 1 B. However, in this analysis the animals were scored until day 4 of adulthood. (B) Wild-type and viable sulp mutant C. elegans were cultured on ΔmoaA mutant (red, Moco−) E. coli and assessed for the formation of xanthine stones. Data points represent biological replicates. ****p < 0.0001, ordinary one-way ANOVA. If not indicated, data were not statistically different when compared to the wild type. Complete information regarding individuals scored per biological replicate is found in S2 Table.
https://doi.org/10.1371/journal.pbio.3003410.s002
(EPS)
S3 Fig. Loss of exc-5 modestly enhanced the formation of xanthine stones in an xdh-1 mutant background.
(A) xdh-1(ok3234), exc-5(rh232), exc-5(rh232) xdh-1(ok3234), aex-5(sa23), and aex-5(sa23); xdh-1(ok3234) mutant C. elegans were assessed for xanthine stone formation when cultured on wild-type (WT) E. coli. Individual data points represent biological replicates. Mean and standard deviation are displayed. ****p < 0.0001, ns, p > 0.05, ordinary one-way ANOVA. Complete information regarding sample size and individuals scored per biological replicate is found in S2 Table. (B–D) Differential interference contrast (top) and fluorescence imaging (bottom) are displayed for (B) WT, (C) exc-5(rh232), or (D) sulp-4(rae319) C. elegans expressing the qpIs11 (Pvha-1::GFP) transgene, which marks the excretory cell. For images of whole animals (left panels), the blue (anterior) and red (posterior) boxes identify the regions displayed in the panels on the right. For images of whole animals (left panels), scale bar is 100 μm. For images of anterior (blue box) and posterior (red box) excretory cell tubule extension, scale bar is 25 μm.
https://doi.org/10.1371/journal.pbio.3003410.s003
(EPS)
S4 Fig. cdo-1 was necessary for the enhanced formation of xanthine stones caused by sulp-4 inactivation during dietary Moco deficiency.
sulp-4(rae319), sulp-4(rae319); cdo-1(mg622), and sulp-4(rae319); moc-1(ok366) cdo-1(mg622) mutant C. elegans were cultured on wild-type (black, Moco+) or ΔmoaA mutant (red, Moco−) E. coli and assessed for the formation of xanthine stones over the first 3 days of adulthood. Mean and standard deviation are displayed. Complete information regarding sample size and individuals scored per biological replicate is found in S2 Table.
https://doi.org/10.1371/journal.pbio.3003410.s004
(EPS)
S5 Fig. Elemental analyses of wild-type and sulp-4 mutant C. elegans.
ICP-MS analysis was performed on extracts from large cultures of young adult wild-type and sulp-4(rae319) mutant C. elegans to determine the concentrations of (A) potassium, (B) sulfur, (C) iron, (D) zinc, (E) manganese, (F) copper, and (G) molybdenum. Individual data points represent biological replicates. Mean and standard deviation are displayed. ns, p > 0.05, t test.
https://doi.org/10.1371/journal.pbio.3003410.s005
(EPS)
S6 Fig. hmit-1.1 and gpdh-1 were not necessary for the enhanced formation of xanthine stones caused by sulp-4 inactivation during dietary Moco deficiency.
Relative mRNA expression of (A) hmit-1.1 and (B) gpdh-1 are displayed for total RNA isolated from wild-type, sulp-4(rae319), and osm-8(n1518) young adult C. elegans. Relative mRNA abundance was determined via the delta-delta CT method. All transcripts are normalized to act-1. Relative mRNA abundance for each transcript was set to one in the wild type. *p < 0.05, ns, p > 0.05, ordinary one-way ANOVA. (C) Wild type and mutant C. elegans were cultured on ΔmoaA mutant (red, Moco−) E. coli and assessed for the formation of xanthine stones. Individual data points represent biological replicates. Mean and standard deviation are displayed. ns, p > 0.05, ordinary one-way ANOVA. Complete information regarding sample size and individuals scored per biological replicate is found in S2 Table.
https://doi.org/10.1371/journal.pbio.3003410.s006
(EPS)
S1 Table. EMS-induced lesions in sulp-4 that promoted the formation of xanthine stones in xdh-1(ok3234)-mutant C. elegans.
https://doi.org/10.1371/journal.pbio.3003410.s007
(XLSX)
S2 Table. Raw data and information regarding sample sizes and biological replicates.
https://doi.org/10.1371/journal.pbio.3003410.s008
(XLSX)
Acknowledgments
Some C. elegans strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). We thank the lab of Emily Troemel for providing a C. elegans strain carrying the pnp-1(jy121) mutation. We thank the lab of Keith Nehrke for providing the Psulp-4::SULP-4::GFP plasmid (pTS1). ICP-MS measurements were performed in the OHSU Elemental Analysis Core with partial support from NIH (S10OD028492).
References
- 1. Mullen NJ, Singh PK. Nucleotide metabolism: a pan-cancer metabolic dependency. Nat Rev Cancer. 2023;23(5):275–94. pmid:36973407
- 2. Lesch M, Nyhan WL. A familial disorder of uric acid metabolism and central nervous system function. Am J Med. 1964;36:561–70. pmid:14142409
- 3. Giblett ER, Ammann AJ, Wara DW, Sandman R, Diamond LK. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet. 1975;1(7914):1010–3. pmid:48676
- 4. Duran M, Beemer FA, van de Heiden C, Korteland J, de Bree PK, Brink M, et al. Combined deficiency of xanthine oxidase and sulphite oxidase: a defect of molybdenum metabolism or transport? J Inherit Metab Dis. 1978;1(4):175–8. pmid:117254
- 5. Dent CE, Philpot GR. Xanthinuria, an inborn error (or deviation) of metabolism. Lancet. 1954;266(6804):182–5. pmid:13118765
- 6. Ball EG. Xanthine oxidase: purification and properties. J Biol Chem. 1939;128(1):51–67.
- 7. Sebesta I. Genetic disorders resulting in hyper- or hypouricemia. Adv Chronic Kidney Dis. 2012;19(6):398–403. pmid:23089275
- 8. Warnhoff K, Ruvkun G. Molybdenum cofactor transfer from bacteria to nematode mediates sulfite detoxification. Nat Chem Biol. 2019;15(5):480–8. pmid:30911177
- 9. Schwarz G, Mendel RR, Ribbe MW. Molybdenum cofactors, enzymes and pathways. Nature. 2009;460(7257):839–47. pmid:19675644
- 10. Snoozy J, Breen PC, Ruvkun G, Warnhoff K. moc-6/MOCS2A is necessary for molybdenum cofactor synthesis in C. elegans. MicroPubl Biol. 2022;2022. pmid:35224462
- 11. Warnhoff K, Hercher TW, Mendel RR, Ruvkun G. Protein-bound molybdenum cofactor is bioavailable and rescues molybdenum cofactor-deficient C. elegans. Genes Dev. 2021;35(3–4):212–7. pmid:33446569
- 12. Oliphant KD, Fettig RR, Snoozy J, Mendel RR, Warnhoff K. Obtaining the necessary molybdenum cofactor for sulfite oxidase activity in the nematode Caenorhabditis elegans surprisingly involves a dietary source. J Biol Chem. 2023;299(1):102736. pmid:36423681
- 13. Sherman T, Chernova MN, Clark JS, Jiang L, Alper SL, Nehrke K. The abts and sulp families of anion transporters from Caenorhabditis elegans. Am J Physiol Cell Physiol. 2005;289(2):C341-51. pmid:15814591
- 14. Nelson FK, Riddle DL. Functional study of the Caenorhabditis elegans secretory-excretory system using laser microsurgery. J Exp Zool. 1984;231(1):45–56. pmid:6470649
- 15. Rohlfing A-K, Miteva Y, Moronetti L, He L, Lamitina T. The Caenorhabditis elegans mucin-like protein OSM-8 negatively regulates osmosensitive physiology via the transmembrane protein PTR-23. PLoS Genet. 2011;7(1):e1001267. pmid:21253570
- 16. Chalmers RA, Watts RW, Pallis C, Bitensky L, Chayen J. Crystalline deposits in striped muscle in xanthinuria. Nature. 1969;221(5176):170–1. pmid:5782709
- 17. Watts RW, Engelman K, Klinenberg JR, Seegmiller JE, Sjoerdsma A. Enzyme defect in a case of xanthinuria. Nature. 1964;201:395–6. pmid:14110004
- 18. Ma X, Wang W, Bittner F, Schmidt N, Berkey R, Zhang L, et al. Dual and opposing roles of xanthine dehydrogenase in defense-associated reactive oxygen species metabolism in Arabidopsis. Plant Cell. 2016;28(5):1108–26. pmid:27152019
- 19. Chi T, Kim MS, Lang S, Bose N, Kahn A, Flechner L, et al. A Drosophila model identifies a critical role for zinc in mineralization for kidney stone disease. PLoS One. 2015;10(5):e0124150. pmid:25970330
- 20. Glassman E, Mitchell HK. Mutants of Drosophila melanogaster deficient in xanthine dehydrogenase. Genetics. 1959;44(2):153–62. pmid:17247815
- 21. Takagaki N, Ohta A, Ohnishi K, Kawanabe A, Minakuchi Y, Toyoda A, et al. The mechanoreceptor DEG-1 regulates cold tolerance in Caenorhabditis elegans. EMBO Rep. 2020;21(3):e48671. pmid:32009302
- 22. Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77(1):71–94. pmid:4366476
- 23. Cho SW, Lee J, Carroll D, Kim J-S, Lee J. Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9-sgRNA ribonucleoproteins. Genetics. 2013;195(3):1177–80. pmid:23979576
- 24. Ghanta KS, Mello CC. Melting dsDNA donor molecules greatly improves precision genome editing in Caenorhabditis elegans. Genetics. 2020;216(3):643–50. pmid:32963112
- 25. Tecle E, Chhan CB, Franklin L, Underwood RS, Hanna-Rose W, Troemel ER. The purine nucleoside phosphorylase pnp-1 regulates epithelial cell resistance to infection in C. elegans. PLoS Pathog. 2021;17(4):e1009350. pmid:33878133
- 26. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403–10. pmid:2231712
- 27. Buechner M. Tubes and the single C. elegans excretory cell. Trends Cell Biol. 2002;12(10):479–84. pmid:12441252
- 28. Suzuki N, Buechner M, Nishiwaki K, Hall DH, Nakanishi H, Takai Y, et al. A putative GDP-GTP exchange factor is required for development of the excretory cell in Caenorhabditis elegans. EMBO Rep. 2001;2(6):530–5. pmid:11415987
- 29. Branicky R, Hekimi S. What keeps C. elegans regular: the genetics of defecation. Trends Genet. 2006;22(10):571–9. pmid:16911844
- 30. Thomas JH. Genetic analysis of defecation in Caenorhabditis elegans. Genetics. 1990;124(4):855–72. pmid:2323555
- 31. Warnhoff K, Bhattacharya S, Snoozy J, Breen PC, Ruvkun G. Hypoxia-inducible factor induces cysteine dioxygenase and promotes cysteine homeostasis in Caenorhabditis elegans. Elife. 2024;12:RP89173. pmid:38349720
- 32. Stipanuk MH, Ueki I. Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfur. J Inherit Metab Dis. 2011;34(1):17–32. pmid:20162368
- 33. Dissanayake LV, Zietara A, Levchenko V, Spires DR, Burgos Angulo M, El-Meanawy A, et al. Lack of xanthine dehydrogenase leads to a remarkable renal decline in a novel hypouricemic rat model. iScience. 2022;25(9):104887. pmid:36039296
- 34. Rohlfing A-K, Miteva Y, Hannenhalli S, Lamitina T. Genetic and physiological activation of osmosensitive gene expression mimics transcriptional signatures of pathogen infection in C. elegans. PLoS One. 2010;5(2):e9010. pmid:20126308
- 35. Lamitina T, Huang CG, Strange K. Genome-wide RNAi screening identifies protein damage as a regulator of osmoprotective gene expression. Proc Natl Acad Sci U S A. 2006;103(32):12173–8. pmid:16880390
- 36. Lamitina ST, Morrison R, Moeckel GW, Strange K. Adaptation of the nematode Caenorhabditis elegans to extreme osmotic stress. Am J Physiol Cell Physiol. 2004;286(4):C785-91. pmid:14644776
- 37. Kage-Nakadai E, Uehara T, Mitani S. H+/myo-inositol transporter genes, hmit-1.1 and hmit-1.2, have roles in the osmoprotective response in Caenorhabditis elegans. Biochem Biophys Res Commun. 2011;410(3):471–7. pmid:21679696
- 38. Lee SD, Choi SY, Lim SW, Lamitina ST, Ho SN, Go WY, et al. TonEBP stimulates multiple cellular pathways for adaptation to hypertonic stress: organic osmolyte-dependent and -independent pathways. Am J Physiol Renal Physiol. 2011;300(3):F707-15. pmid:21209002
- 39. Pais VM Jr, Lowe G, Lallas CD, Preminger GM, Assimos DG. Xanthine urolithiasis. Urology. 2006;67(5):1084.e9-11. pmid:16698380
- 40. Yanagi KS, Jochim B, Kunjo SO, Breen P, Ruvkun G, Lehrbach N. Mutations in nucleotide metabolism genes bypass proteasome defects in png-1/NGLY1-deficient Caenorhabditis elegans. PLoS Biol. 2024;22(7):e3002720. pmid:38991033
- 41. Ast T, Meisel JD, Patra S, Wang H, Grange RMH, Kim SH, et al. Hypoxia rescues frataxin loss by restoring iron sulfur cluster biogenesis. Cell. 2019;177(6):1507-1521.e16. pmid:31031004
- 42. Bantia S, Parker C, Upshaw R, Cunningham A, Kotian P, Kilpatrick JM, et al. Potent orally bioavailable purine nucleoside phosphorylase inhibitor BCX-4208 induces apoptosis in B- and T-lymphocytes—a novel treatment approach for autoimmune diseases, organ transplantation and hematologic malignancies. Int Immunopharmacol. 2010;10(7):784–90. pmid:20399911
- 43. Kamath VP, Juarez-Brambila JJ, Morris PE Jr. Synthesis of labeled BCX-4208, a potent inhibitor of purine nucleoside phosphorylase. Drug Test Anal. 2009;1(3):125–7. pmid:20355185
- 44. Adrogué HJ, Madias NE. Hypernatremia. N Engl J Med. 2000;342(20):1493–9. pmid:10816188
- 45. Prince CL, Scardino PL, Wolan CT. The effect of temperature, humidity and dehydration on the formation of renal calculi. J Urol. 1956;75(2):209–15. pmid:13296117
- 46. Mudd SH, Irreverre F, Laster L. Sulfite oxidase deficiency in man: demonstration of the enzymatic defect. Science. 1967;156(3782):1599–602. pmid:6025118
- 47. Dominy JE Jr, Hirschberger LL, Coloso RM, Stipanuk MH. In vivo regulation of cysteine dioxygenase via the ubiquitin-26S proteasome system. Adv Exp Med Biol. 2006;583:37–47. pmid:17153587
- 48. Dominy JE Jr, Hirschberger LL, Coloso RM, Stipanuk MH. Regulation of cysteine dioxygenase degradation is mediated by intracellular cysteine levels and the ubiquitin-26 S proteasome system in the living rat. Biochem J. 2006;394(Pt 1):267–73. pmid:16262602
- 49. Stipanuk MH, Hirschberger LL, Londono MP, Cresenzi CL, Yu AF. The ubiquitin-proteasome system is responsible for cysteine-responsive regulation of cysteine dioxygenase concentration in liver. Am J Physiol Endocrinol Metab. 2004;286(3):E439-48. pmid:14644768
- 50. Lee J-I, Londono M, Hirschberger LL, Stipanuk MH. Regulation of cysteine dioxygenase and gamma-glutamylcysteine synthetase is associated with hepatic cysteine level. J Nutr Biochem. 2004;15(2):112–22. pmid:14972351
- 51. Kwon YH, Stipanuk MH. Cysteine regulates expression of cysteine dioxygenase and gamma-glutamylcysteine synthetase in cultured rat hepatocytes. Am J Physiol Endocrinol Metab. 2001;280(5):E804-15. pmid:11287364
- 52. Hill AJ, Basourakos SP, Lewicki P, Wu X, Arenas-Gallo C, Chuang D, et al. Incidence of kidney stones in the United States: the continuous national health and nutrition examination survey. J Urol. 2022;207(4):851–6. pmid:34854755
- 53. Jiang Z, Asplin JR, Evan AP, Rajendran VM, Velazquez H, Nottoli TP, et al. Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet. 2006;38(4):474–8. pmid:16532010
- 54. Cornière N, Thomson RB, Thauvin S, Villoutreix BO, Karp S, Dynia DW, et al. Dominant negative mutation in oxalate transporter SLC26A6 associated with enteric hyperoxaluria and nephrolithiasis. J Med Genet. 2022;59(11):1035–43. pmid:35115415
- 55. Gee HY, Jun I, Braun DA, Lawson JA, Halbritter J, Shril S, et al. Mutations in SLC26A1 cause nephrolithiasis. Am J Hum Genet. 2016;98(6):1228–34. pmid:27210743
- 56. Hirata T, Cabrero P, Berkholz DS, Bondeson DP, Ritman EL, Thompson JR, et al. In vivo Drosophilia genetic model for calcium oxalate nephrolithiasis. Am J Physiol Renal Physiol. 2012;303(11):F1555-62. pmid:22993075
- 57. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2006;2:2006.0008. pmid:16738554
- 58. Mattingly BC, Buechner M. The FGD homologue EXC-5 regulates apical trafficking in C. elegans tubules. Dev Biol. 2011;359(1):59–72. pmid:21889936
- 59. Lehrbach NJ, Ji F, Sadreyev R. Next-Generation sequencing for identification of EMS-induced mutations in Caenorhabditis elegans. Curr Protoc Mol Biol. 2017;117:7.29.1-7.29.12. pmid:28060408
- 60. Galaxy Community. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update. Nucleic Acids Res. 2022;50(W1):W345–51. pmid:35446428
- 61. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–20. pmid:24695404
- 62. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26(5):589–95. pmid:20080505
- 63. Wilm A, Aw PPK, Bertrand D, Yeo GHT, Ong SH, Wong CH, et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res. 2012;40(22):11189–201. pmid:23066108
- 64. Cingolani P, Patel VM, Coon M, Nguyen T, Land SJ, Ruden DM, et al. Using Drosophila melanogaster as a model for genotoxic chemical mutational studies with a new program, SnpSift. Front Genet. 2012;3:35. pmid:22435069
- 65. Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6(2):80–92. pmid:22728672
- 66. Mello CC, Kramer JM, Stinchcomb D, Ambros V. Efficient gene transfer in C. elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J. 1991;10(12):3959–70. pmid:1935914
- 67. Stiernagle T. Maintenance of C. elegans. WormBook. 2006:1–11. pmid:18050451
- 68. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–8. pmid:18546601